Regulation of the acid-labile subunit in sustained endotoxemia

American Journal of Physiology - Endocrinology and Metabolism

Volumn 283, Issue 4 46-4, 2002, Pages

  Kong, Sung Eun ^a   Firth, Sue M ^a   Baxter, Robert C ^a   Delhanty, Patric J D ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Insulin sensitivity; Insulin like growth factor binding protein 5; Liver; Ternary complexes

Indexed keywords

ACID LABILE SUBUNIT; ENDOTOXIN; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; INSULIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROTEIN; PROTEIN CIS; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENDOTOXEMIA; FOOD INTAKE; GLUCOSE HOMEOSTASIS; GROWTH RETARDATION; INSULIN SENSITIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; REGULATORY MECHANISM;

EID: 0036785663     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00148.2002     Document Type: Article

References (52)

1. Decreased acid-labile subunit (ALS) levels by endotoxin in vivo and by interleukin-1β in vitro
2. Circulating levels and molecular distribution of the acid-labile (α) subunit of the high molecular weight insulin-like growth factor-binding protein complex
3. Changes in the IGF-IGFBP axis in critical illness
4. Purification and characterization of the acid-labile subunit of rat serum insulin-like growth factor binding protein complex
5. Thirty-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patients
6. Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: Determination by reconstitution and affinity-labeling
7. Molecular distribution of IGF binding protein-5 in human serum
8. Regulation of hepatic growth hormone receptors by insulin
9. Insulin and glucagon regulate cytosolic phosphoenolpyruvate carboxykinase (GTP) mRNA in rat liver
10. Impairment of liver GH receptor signaling by fasting
11. Regulation of the acid-labile subunit of the insulin-like growth factor ternary complex in patients with insulin-dependent diabetes mellitus and severe burns
12. Growth hormone rapidly activates insulin-like growth factor I gene transcription in vivo
13. The acid-labile subunit (ALS) of the 150 kDa IGF-binding protein complex: An important but forgotten component of the circulating IGF system
14. Role of the suppressor of cytokine signaling-3 in mediating the inhibitory effects of interleukin-1β on the growth hormone-dependent transcription of the acid-labile subunit gene in liver cells
15. Potentiation of growth hormone-induced liver suppressors of cytokine signaling messenger ribonucleic acid by cytokines
16. Comparison of extraction methods for insulin-like growth factor-I in rat serum
17. Regulation in vivo of the acid-labile subunit of the rat serum insulin-like growth factor-binding protein complex
18. Regulation of the acid-labile subunit of the insulin-like growth factor complex in cultured rat hepatocytes
19. GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors
20. The expression of insulin-like growth factor (IGF)-binding protein-2 and IGF-II genes in the tissues of the developing ovine fetus
21. Interleukin-1β suppresses growth hormone induced acid-labile subunit mRNA levels and expression in primary hepatocytes
22. The regulation and actions of ALS
23. Cloning and characterisation of the rat gene for the acid-labile subunit of the insulin-like growth factor binding protein complex
24. Alterations in hepatic production and peripheral clearance of IGF-I after endotoxin
25. Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin
26. Changes in the circulating IGF system during short-term fasting and refeeding in rats
27. Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. The role of winged helix/forkhead proteins
28. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins
29. Altered transcriptional regulation of phosphoenolpyruvate carboxykinase in rats following endotoxin treatment
30. Identification of tumor necrosis factor as a transcriptional regulator of the phosphoenolpyruvate carboxykinase gene following endotoxin treatment of mice
31. Growth hormone modulates insulin regulation of hepatic insulin-like growth factor binding protein-1 transcription
32. Differential expression of suppressors of cytokine signalling genes in response to nutrition and growth hormone in the septic rat
33. Endotoxin tolerance diminishes endotoxin-induced alterations in carbohydrate kinetics
34. Regulation of IGF binding protein-1 in Hep G2 cells by cytokines and reactive oxygen species
35. Complex formation by human insulin-like growth factor-binding protein-3 and human acid-labile subunit in growth hormone-deficient rats
36. Regulation of insulin-like growth factor-binding protein-1 in rat serum
37. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo
38. Sustained endotoxemia leads to marked down-regulation of early steps in the insulin-signaling cascade
39. Growth hormone stimulates transcription of the gene encoding the acid-labile subunit (ALS) of the circulating insulin-like growth factor-binding protein complex and ALS promoter activity in rat liver
40. Insulin rapidly decreases insulin-like growth factor-binding protein-1 gene transcription in streptozotocin-diabetic rats
41. Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids mRNA analysis and promoter characterization
42. Endotoxin-induced suppression of the somatotropic axis is mediated by interleukin-1 beta and corticotropin-releasing factor in the juvenile rat
43. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms
44. Effects of endotoxin lipopolysaccharide administration on the somatotropic axis
45. IGF-I/IGFBP-3 binary complex modulates sepsis-induced inhibition of protein synthesis in skeletal muscle
46. Inhibition by interleukin-1β and tumor necrosis factor-α of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture
47. Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease
48. Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit
49. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness
50. Alterations in the insulin-like growth factor system in trauma patients
51. Cell-specific localization of insulin-like growth factor binding protein mRNAs in rat liver
52. Endotoxin tolerance: Independent regulation of interleukin-1 and tumor necrosis factor expression